Background illustration for clinical trials search

Paid Clinical Trials Akron

Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: Cleveland OH, Ann Arbor MI, Amherst NY, Cincinnati OH,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease

for
Parkinson's Disease
Location: Cleveland OH
Sponsor: VA Office of Research and Development

Sex: All

Age: 0+

Code: NCT05400499

Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Celveland OH, Sewickley PA, Monroeville PA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase 3, Recruiting

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

for
Mitral Valve Regurgitation
Location: Cleveland OH, Pittsburgh PA, Columbus OH, Detroit MI,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18+

Code: NCT03242642

Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Cleveland OH, Buffalo NY, Cincinnati OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Cleveland OH, Columbus OH, Toledo OH, Detroit MI,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

for
Hypoxic-Ischemic Encephalopathy
Location: Cleveland OH, Morgantown WV, Indianapolis IN,
Sponsor: ReAlta Life Sciences, Inc.

Sex: All

Age: 0

Code: NCT05778188

Phase 2, Phase 3, Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for
Liver Diseases, Alcoholic
Location: Cleveland OH, London, Toronto, Indianapolis IN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70

Code: NCT06613698

Phase 2, Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

for
Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Location: Cleveland OH, Cincinnati OH, Indianapolis IN,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07010159

Phase 2, Phase 3, Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

for
NSCLC Stage IV
Location: Cleveland OH, Windsor, London, Kitchener, Brampton,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase 3, Recruiting

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

for
Higher-risk Myelodysplastic Syndrome
Location: Cleveland OH, Pittsburgh PA, Columbus OH, Rochester NY,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06641414

Phase 3, Recruiting

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

for
Castration-Resistant Prostate Carcinoma,
Location: Warren OH, Youngstown OH, Boardman OH, Findlay OH,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT06470243

Phase 3, Recruiting

Transition to KPL-387 Monotherapy Dosing & Administration Study

for
Recurrent Pericarditis, Heart Diseases, Pericarditis
Location: Cleveland OH, Cincinnati OH, Charlottesville VA,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07288216

Phase 2, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: Cleveland OH, Royal Oak MI, Ann Arbor MI, Amherst NY,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase 3, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Cleveland OH, Pittsburgh PA, Detroit MI, Ann Arbor MI,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase 3, Recruiting

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for
Solid Tumor
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06874335

Phase 1, Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Cleveland OH, Farmington MI, Dayton OH, Cincinnati OH,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase 3, Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

for
Interstitial Lung Disease
Location: Cleveland OH, Chicago IL, Richmond VA, New York NY,
Sponsor: aTyr Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05892614

Phase 2, Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

for
B-cell Mediated Autoimmune Disorders
Location: Cleveland OH, Columbus OH, Ann Arbor MI, Rochester NY,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06680037

Phase 1, Recruiting

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for
Gastroesophageal-junction Cancer, Monoclonal Antibody,
Location: Cleveland OH, Pittsburgh PA, Morgantown WV, Sayre PA,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT06532006

Phase 3, Recruiting